03:05 PM EST, 01/23/2025 (MT Newswires) -- AstraZeneca ( AZN ), , a global pharmaceutical company, Thursday announced a C$820 million investment in Canada, which is expected to create more than 700 jobs.

According to a statement, the investment will support the move to a larger, state-of-the-art office facility in the Greater Toronto Area (GTA), Ontario.

Gaby Bourbara, President, AstraZeneca Canada said in the statement: "AstraZeneca's ( AZN ) continued investment in Ontario is crucial to advancing innovative medicines that treat, prevent, and may one day cure complex diseases like prostate, lung, and breast cancer, as well as rare diseases. AstraZeneca's ( AZN ) investment of C$820 million (US$570m), alongside the Government of Ontario's contribution through Invest Ontario, will strengthen the Province's life sciences strategy, driving economic growth, and foster innovation that benefits patients in Canada and around the world."

Price: 68.44, Change: +0.23, Percent Change: +0.34